| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Pathology Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104 [H. N., Y. M., K. I., T. O., S. H.]; Department of Surgery, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160 [H. N., M. K.]; Central Laboratories for Key Technology, Kirin Brewery Co., Ltd., 1-13-5 Fukuura, Kanazawa-ku, Yokohama-shi, Kanagawa 236 [N. K., A. I.]; and Fuji Research Laboratories, Kyowa Medex Co., Ltd., 600-1 Minami-ishiki, Nagaizumi-cho, Sunto-gun, Shizuoka 411 [H. K., S. S.], Japan
Recent studies have shown that various tumor cells accumulate ubiquitin (Ub)-conjugated proteins, the profiles of which differ from those of normal cells. To identify the Ub-conjugated proteins accumulated specifically by human carcinoma cells, a two-dimensional immunoblot analysis of 31 surgically resected human primary colorectal carcinoma tissues was performed using an anti-Ub monoclonal antibody, KM691. Two distinct Mr 42,000 and 45,000 proteins in the Triton X-insoluble fractions of carcinoma tissues reacted with this antibody, whereas only one Mr 45,000 protein reacted in normal tissues. The Mr 42,000 Ub-conjugated proteins were specific to carcinoma tissues from 25 patients (80.6%). One of the purified Mr 42,000 proteins was digested with Achromobacter protease I. This protein was identified as a cytokeratin 8 (CK 8) fragment based on both molecular mass determination and molecular mass searching of Achromobacter protease I-digested fragments of proteins registered in a protein sequence data base. Two-dimensional immunoblot analysis with an anti-CK 8 antibody confirmed that all of the Mr 42,000 proteins were CK 8 degradation products. These results demonstrate that human colorectal carcinomas specifically accumulate Mr 42,000 Ub-conjugated CK 8 fragments. This accumulation was observed frequently not only in advanced (18/22, 81.8%), but also in early stage cases (7/9, 77.8%), suggesting that it occurs even in the early stages of colorectal carcinoma progression.
1 This work was supported by a Grant-in-Aid for the Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health and Welfare of Japan.
2 Awardee of a Research Resident Fellowship from the Foundation for Promotion of Cancer Research.
3 To whom requests for reprints should be addressed.
Received 11/ 8/95. Accepted 4/11/96.
This article has been cited by other articles:
![]() |
H. J. Ditzel, M. C. M. Strik, M. K. Larsen, A. C. Willis, A. Waseem, K. Kejling, and J. C. Jensenius Cancer-associated Cleavage of Cytokeratin 8/18 Heterotypic Complexes Exposes a Neoepitope in Human Adenocarcinomas J. Biol. Chem., June 7, 2002; 277(24): 21712 - 21722. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Masdehors, H. Merle-Beral, K. Maloum, S. Omura, H. Magdelenat, and J. Delic Deregulation of the ubiquitin system and p53 proteolysis modify the apoptotic response in B-CLL lymphocytes Blood, July 1, 2000; 96(1): 269 - 274. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.-O. Ku and M. B. Omary Keratins Turn Over by Ubiquitination in a Phosphorylation-modulated Fashion J. Cell Biol., May 1, 2000; 149(3): 547 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Tamura and A. Nittayajarn Group B Streptococci and Other Gram-Positive Cocci Bind to Cytokeratin 8 Infect. Immun., April 1, 2000; 68(4): 2129 - 2134. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.-O. Ku, X. Zhou, D. M. Toivola, and M. B. Omary The cytoskeleton of digestive epithelia in health and disease Am J Physiol Gastrointest Liver Physiol, December 1, 1999; 277(6): G1108 - G1137. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Ditzel, U. Garrigues, C. B. Andersen, M. K. Larsen, H. J. Garrigues, A. Svejgaard, I. Hellstrom, K. E. Hellstrom, and J. C. Jensenius Modified cytokeratins expressed on the surface of carcinoma cells undergo endocytosis upon binding of human monoclonal antibody and its recombinant Fab fragment PNAS, July 22, 1997; 94(15): 8110 - 8115. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Eto, S. S. Yoon, B. P. Bode, S. Kamidono, K. Makino, H. Saya, H. Nakamura, and K. K. Tanabe Mapping and Regulation of the Tumor-associated Epitope Recognized by Monoclonal Antibody RS-11 J. Biol. Chem., August 25, 2000; 275(35): 27075 - 27083. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |